H

Huaxia Eye Hospital Group Co Ltd
SZSE:301267

Watchlist Manager
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Watchlist
Price: 20.18 CNY -0.1% Market Closed
Market Cap: 17B CNY
Have any thoughts about
Huaxia Eye Hospital Group Co Ltd?
Write Note
Huaxia Eye Hospital Group Co Ltd
/
Balance Sheet
/
Current Portion of Long-Term Debt

Huaxia Eye Hospital Group Co Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Huaxia Eye Hospital Group Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Current Portion of Long-Term Debt
¥117.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Current Portion of Long-Term Debt
¥63.7m
CAGR 3-Years
236%
CAGR 5-Years
42%
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Current Portion of Long-Term Debt
¥814.9m
CAGR 3-Years
5%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Hengkang Medical Group Co Ltd
SZSE:002219
Current Portion of Long-Term Debt
¥358.2m
CAGR 3-Years
171%
CAGR 5-Years
43%
CAGR 10-Years
80%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Current Portion of Long-Term Debt
¥783.1m
CAGR 3-Years
26%
CAGR 5-Years
104%
CAGR 10-Years
43%
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Current Portion of Long-Term Debt
¥36.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Huaxia Eye Hospital Group Co Ltd
Glance View

Market Cap
17B CNY
Industry
Health Care

Huaxia Eye Hospital Group Co Ltd has positioned itself as a key player in China’s healthcare landscape, specializing in comprehensive ophthalmic services. Emerging from the early stirrings of China's reforms in the healthcare sector, Huaxia capitalized on a burgeoning demand for specialized medical care. With roots tracing back to when accessible eye care was a luxury in China, Huaxia recognized the immense potential in providing quality eye treatments. As the country urbanized rapidly, vision ailments became increasingly prevalent, creating a vast market for ocular health services. Huaxia seized this opportunity by establishing a network of state-of-the-art facilities across major cities, providing services ranging from basic eye examinations to complex surgeries. The company's revenue model is built on a multifaceted approach, combining patient volume with specialized treatments. Catering to a diverse demographic, Huaxia offers tiered service options that suit various financial capacities, ensuring a steady stream of income. Beyond individual consultations, the company has fostered partnerships with corporations and insurance providers, further securing a stable client base. Moreover, Huaxia invests significantly in pioneering medical technology and staff training, enhancing its reputation and thereby drawing more patients seeking top-notch care. Through strategic expansion and consistently leveraging advancements in ophthalmology, Huaxia Eye Hospital Group Co Ltd has solidified its place not just as a healthcare provider, but as a critical architect shaping the future of eye care in China.

Intrinsic Value
30.66 CNY
Undervaluation 34%
Intrinsic Value
Price
H
What is Intrinsic Value?

See Also

What is Huaxia Eye Hospital Group Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
117.2m CNY

Based on the financial report for Dec 31, 2023, Huaxia Eye Hospital Group Co Ltd's Current Portion of Long-Term Debt amounts to 117.2m CNY.

What is Huaxia Eye Hospital Group Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 1Y
21%

Over the last year, the Current Portion of Long-Term Debt growth was 21%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.